Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency
Biocon said the CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is expected early next year.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Diabetes | Endocrinology | European Medicines Agency (EMA) | Pharmaceuticals